Clinical trial
Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After…
NCT00064779 · INSYS Therapeutics Inc, Industry · Completed
Key facts
| NCT number | NCT00064779 |
|---|---|
| Title | Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma |
| Official title | Pilot Imaging Study to Assess the Distribution of IL13-PE38QQR Cytotoxin Infusions in Patients With Recurrent, Resectable, Supratentorial Malignant Glioma |
| Lead sponsor | INSYS Therapeutics Inc, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Mixed Oligoastrocytoma |
| Intervention type | Drug, Procedure |
| Interventions | IL13-PE38QQR, targeted fusion protein therapy, surgery |
| Enrollment | 18 |
| Start date | Jul 1, 2003 |
| Primary completion | Jun 1, 2006 |
| Completion | Jul 1, 2007 |
| First posted | Jul 15, 2003 |
| Last update posted | Jun 6, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: